Physical Medicine & Rehabilitation, Pain Medicine · Levittown, NY
NPI
1275760100
Since 2009
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Jerusalem Ave
Levittown, NY, 11756
Phone (516) 513-0836
Medicare paid, 2024
$177K
1,215 services
Medicare patients, 2024
205
Average age 69
Drug cost, 2024
$469K
401 prescriptions
Company payments, 2025
$1,299
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed A Hadi was code 99214 (office e&m - established), 409 times for 184 patients. In total Mohammed A Hadi billed 1,215 services in 50 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 409 | 184 | $98.65 | $40K |
| 80307 Drug Tests | Office | 132 | 86 | $60.90 | $8,039 |
| 64484 Nerve Block Injection - Back | Office | 73 | 40 | $115.98 | $8,466 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 72 | 51 | $153.46 | $11K |
| 64483 Nerve Block Injection - Back | Office | 57 | 40 | $269.33 | $15K |
| 64493 Nerve Block Injection - Back | Office | 55 | 41 | $215.18 | $12K |
| 64494 Nerve Block Injection - Back | Office | 55 | 41 | $110.98 | $6,104 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 44 | 34 | $194.77 | $8,570 |
| 64491 Nerve Block Injection - Back | Office | 33 | 23 | $117.72 | $3,885 |
| 64490 Nerve Block Injection - Back | Office | 27 | 22 | $232.64 | $6,281 |
| 20610 Joint Injection | Office | 24 | 15 | $60.33 | $1,448 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 13 | $13.24 | $185 |
| 20611 Joint Injection | Office | 13 | 11 | $88.30 | $1,148 |
| 99204 Office E&M - New | Office | 12 | 12 | $133.50 | $1,602 |
By year: 2022 $662K for 5,732 services; 2023 $376K for 3,204 services; 2024 $177K for 1,215 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 132 | 86 | $60.90 | $8,039 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 72 | 51 | $153.46 | $11K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 44 | 34 | $194.77 | $8,570 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed A Hadi prescribed most often to Medicare patients was Gabapentin, with 37 prescriptions and refills. In total Mohammed A Hadi wrote 401 Medicare prescriptions that cost $469K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 37 | 39 | 22 | $392 |
| Diclofenac Sodium Generic | 32 | 47 | 14 | $43K |
| Movantik Naloxegol Oxalate | 23 | 25 | Under 11 | $9,969 |
| Tizanidine Hcl Generic | 22 | 26 | Under 11 | $325 |
| Cyclobenzaprine Hcl Generic | 21 | 21 | Under 11 | $227 |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 18 | 28 | Under 11 | $48K |
| Clemastine Fumarate Generic | 17 | 21 | Under 11 | $198K |
| Mounjaro Tirzepatide | 14 | 14 | Under 11 | $14K |
| Lidocaine Generic | 13 | 13 | Under 11 | $1,488 |
| Baclofen Generic | 12 | 17 | Under 11 | $117 |
Brand drugs: 94 claims; generic drugs: 307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed A Hadi $1,299 ($1,299 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $412.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $412 |
| Protega Pharmaceutials Inc | 10 | $185 |
| Collegium Pharmaceutical, Inc. COLL | 11 | $164 |
| Axsome Therapeutics, Inc. AXSM | 3 | $80.62 |
| Scilex Pharmaceuticals Inc. | 4 | $75.85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68.3 |
| Azurity Pharmaceuticals, Inc. | 3 | $58.45 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $51.77 |
| Novo Nordisk Inc NVO | 2 | $42.68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $42.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.